| Etiology and long-term outcome of extrahepatic portal vein obstruction in children. | |
| | |
MedLine Citation:
|
PMID: 20954284 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
AIM: To study the management and outcome of children with extrahepatic portal vein obstruction (EHPVO) in a whole country population. METHODS: A nationwide multicenter retrospective case series of children with EHPVO was conducted. Data on demographics, radiographic studies, laboratory workup, endoscopic and surgical procedures, growth and development, were extracted from the patients' charts. Characteristics of clinical presentation, etiology of EHPVO, management and outcome were analyzed. RESULTS: Thirty patients, 13 males and 17 females, 19 (63.3%) Israeli and 11 (36.7%) Palestinians, were included in the analysis. Age at presentation was 4.8 ± 4.6 years, and mean follow-up was 4.9 ± 4.3 years. Associated anomalies were found in 4 patients. The incidence of EHPVO in Israeli children aged 0-14 years was 0.72/million. Risk factors for EHPVO were detected in 13 (43.3%) patients, including 9 patients (30%) with perinatal risk factors, and 4 patients (13.3%) with prothrombotic states: two had low levels of protein S and C, one had lupus anticoagulant, and one was homozygous for methyltetrahydrofolate reductase mutations. In 56.6% of patients, no predisposing factors were found. The most common presenting symptoms were an incidental finding of splenomegaly (43.3%), and upper gastrointestinal bleeding (40%). No differences were found between Israeli and Palestinian children with regard to age at presentation, etiology and clinical symptoms. Bleeding occurred in 18 patients (60%), at a median age of 3 years. Sclerotherapy or esophageal banding was performed in 20 patients. No sclerotherapy complications were reported. Portosystemic shunts were performed in 11 patients (36.6%), at a median age of 11 (range 3-17) years: splenorenal in 9, mesocaval in 1, and a meso-Rex shunt in 1 patient. One patient underwent splenectomy due to severe pancytopenia. Patients were followed up for a median of 3 (range 0.5-15) years. One patient died aged 3 years due to mucopolysaccharidase deficiency type III. None of the patients died due to gastrointestinal bleeding. CONCLUSION: EHPVO is a rare disorder. The etiological factors are still mostly unknown, and the endoscopic and surgical treatment options ensure a good long-term prognosis. |
| | |
Authors:
|
Batia Weiss; Eyal Shteyer; Asaf Vivante; Drora Berkowitz; Shimon Reif; Zvi Weizman; Yoram Bujanover; Rivka Shapiro |
Related Documents
:
|
12586814 - Minidose warfarin prophylaxis for catheter-associated thrombosis in cancer patients: ca... 16704544 - Hemorheology in patients with liver cirrhosis: special emphasis on its relation to seve... 9181754 - Haemostatical and rheological aspects of dysfibrinogenemia. 2022144 - Analysis of the colonoscopic findings in patients with rectal bleeding according to the... 20616414 - Adenomatous colorectal polyps in patients referred for colonoscopy in a regional hospit... 19327604 - Skin findings in thyroid diseases. |
Publication Detail:
|
Type: Journal Article; Multicenter Study |
Journal Detail:
|
Title: World journal of gastroenterology : WJG Volume: 16 ISSN: 1007-9327 ISO Abbreviation: World J. Gastroenterol. Publication Date: 2010 Oct |
Date Detail:
|
Created Date: 2010-10-18 Completed Date: 2011-02-01 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 100883448 Medline TA: World J Gastroenterol Country: China |
Other Details:
|
Languages: eng Pagination: 4968-72 Citation Subset: IM |
Affiliation:
|
Division of Pediatric Gastroenterology, Hepatology and Nutrition, Edmond and Lily Safra Children's Hospital, Tel-Hashomer, 52625, Israel. weissb@sheba.health.gov.il |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adolescent Child Child, Preschool Endoscopy Esophageal and Gastric Varices / etiology Female Gastrointestinal Hemorrhage / etiology Humans Hypertension, Portal / etiology Incidence Infant Infant, Newborn Israel Male Portal Vein* Portasystemic Shunt, Surgical Retrospective Studies Risk Factors Sclerotherapy Splenectomy Time Factors Treatment Outcome Vascular Diseases / epidemiology, etiology*, therapy |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Association of p53/p21 expression with cigarette smoking and prognosis in esophageal squamous cell c...
Next Document: Glycemic index, glycemic load and insulinemic index of Chinese starchy foods.